Building Best-in-Class Medical Affairs Capabilities In India – Budget and Staffing Trends in Emerging Markets

STUDY OVERVIEW

Pharmaceutical Medical Affairs organizations bridge the gap between commercial and R&D operations and hence are critical for biopharma and medical device organization future growth. In fact, the call for increased transparency in the recent years has increased the responsibility of Medical Affairs at many companies. However, Medical Affairs at many companies in emerging countries, especially India, is still in its infancy. Moreover, Medical Affairs groups in India lack clear value proposition to evolve beyond their traditional role.

Best Practices, LLC's recent case study illustrates how mature and Indian biopharmaceutical companies are allocating their Medical Affairs budget. The study also reviews where FTEs are allocated across the different functions within Medical Affairs, which roles have increased in importance and Medical Affairs budget trends.

KEY TOPICS

• Medical Affairs: Spend Allocation     
• Medical Affairs: Staffing 
• Medical Affairs: Functional Responsibility     
• Medical Affairs: Budget Trends & Success Factors 
• Participant Demographic Data 

• Percent of Medical Affairs spend allocated to key MA functions
• Percent of Medical Affairs FTEs staffed to key functional areas
• Percent of Medical Affairs spend allocated for outsourcing
• Which key Medical Affairs functions have become more important
• What changes in budget and FTE resource levels have you experienced 2011 to 2012 and 2012 to 2013

• Spending Highest in Medical Clinical Operations: In India a major part of the Medical Affairs budget (43%) goes to Medical and Clinical research operations, while 25% of  MA spend in mature markets goes to  Medical & Clinical research operations. Smaller portions are allocated to Medical Science Liaisons, Medical Education and Outcomes Research. With Medical Affairs in its early stages in India MSL, MedEd and Outcomes groups are non-existent or in their infancy.

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.